The use of the comet assay for the evaluation of the genotoxicity of nanomaterials

The accelerating production and use of engineered nanomaterials (NMs) raises questions about the safety of this new technology. To avoid the possible hazards associated with NMs requires proper regulation. How should toxicity testing be addressed and can standard tests for assessment of safety of chemicals be applied to NMs? What are the major limitations of NM safety testing and is the current regulatory testing strategy suitable also for NMs? Can existing tests be fully adapted or should new methods be developed to suit the unique properties of NMs?

[1]  H. Karlsson,et al.  The comet assay in nanotoxicology research , 2010, Analytical and bioanalytical chemistry.

[2]  Markus Schulz,et al.  Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations--many questions, some answers. , 2009, Mutation research.

[3]  Richard A. Anderson,et al.  development in vitro , 2008 .

[4]  Maria Dusinska,et al.  Can the comet assay be used reliably to detect nanoparticle‐induced genotoxicity? , 2015, Environmental and molecular mutagenesis.

[5]  Maria Dusinska,et al.  Can Standard Genotoxicity Tests be Applied to Nanoparticles? , 2012, Journal of toxicology and environmental health. Part A.

[6]  M. Kirsch‐Volders,et al.  Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials. , 2011, Mutagenesis.

[7]  H. Karlsson,et al.  DNA damage induced by micro- and nanoparticles--interaction with FPG influences the detection of DNA oxidation in the comet assay. , 2012, Mutagenesis.

[8]  Albert Duschl,et al.  The suitability of different cellular in vitro immunotoxicity and genotoxicity methods for the analysis of nanoparticle-induced events , 2010, Nanotoxicology.

[9]  Fabrice Nesslany,et al.  Genotoxicity of Nanoparticles , 2015 .

[10]  P. M. Williams,et al.  Confounding experimental considerations in nanogenotoxicology. , 2009, Mutagenesis.

[11]  Jérôme Labille,et al.  Modifications of the bacterial reverse mutation test reveals mutagenicity of TiO(2) nanoparticles and byproducts from a sunscreen TiO(2)-based nanocomposite. , 2012, Toxicology letters.

[12]  Maria Dusinska,et al.  Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests , 2015, Nanotoxicology.

[13]  Tao Chen,et al.  Genotoxicity evaluation of titanium dioxide nanoparticles using the Ames test and Comet assay , 2012, Journal of applied toxicology : JAT.

[14]  Helinor Johnston,et al.  Development of in vitro systems for nanotoxicology: methodological considerations , 2009, Critical reviews in toxicology.

[15]  Maria Dusinska,et al.  Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles , 2014, Nanotoxicology.

[16]  G. Jenkins,et al.  In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines , 2012, Mutation research.